VAERS Explorer
Back to explore

Report #2853920

Received Aug 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
TX
Recovered
Unknown
Vaccinated
Jul 19, 2025
Onset
Jul 19, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPAHEP A (VAQTA)MERCK & CO. INC.UNKY014585—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

patient is not experiencing any symptoms/side effects; a VAQTA product was administered to a patient in which a TE assessment had been completed; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 19-JUL-2025, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) suspension for injection at a dose of 0.5 mL, lot #Y014585, expiration date: 01-FEB-2026, for prophylaxis (route of administration and anatomical location were not reported). Before administration, the vaccine underwent temperature excursions (10 min in 50.5 F, 1 hour in -8.5 degrees Celsius); the temperature excursion assessment was completed on 22-JUL-2025 (Product storage error). The patient is not experiencing any symptoms or side effects.